Boothbay Fund Management’s LENZ Therapeutics LENZ Stock Holding History

Boothbay Fund Management’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-39,746	Closed	-$1.15M	–	1846
2024 Q4	$1.15M	Sell	39,746 -14,633	-27%	-$446K	0.03%	602
2024 Q3	$1.29M	Hold	54,379	–	–	0.03%	677
2024 Q2	$940K	Buy	54,379 +31,778	+141%	+$555K	0.02%	742
2024 Q1	$505K	Buy	+22,601	New	+$470K	0.01%	998
2023 Q1	–	Sell	-4,066	Closed	-$94.5K	–	2558
2022 Q4	$94.5K	Buy	+4,066	New	+$94.2K	﹤0.01%	1801
2022 Q3	–	Sell	-2,006	Closed	-$39K	–	2660
2022 Q2	$39K	Buy	+2,006	New	+$44.7K	﹤0.01%	2101

Other funds holding LENZ

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return